JOSÉ MANUEL
ZUBELDIA ORTUÑO
Profesor titular de universidad
Publicaciones (92) Publicaciones de JOSÉ MANUEL ZUBELDIA ORTUÑO
2024
-
Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing
Journal of Asthma, Vol. 61, Núm. 1, pp. 69-71
2023
-
Oral Immunotherapy and Risk of Eosinophilic Esophagitis in Children: 15 Years' Experience
Journal of pediatric gastroenterology and nutrition, Vol. 76, Núm. 1, pp. 53-58
2022
-
Eosinophilic Esophagitis Caused by Grass Pollen Sublingual Immunotherapy With Tolerance to a Subcutaneous Extract
Journal of Investigational Allergology and Clinical Immunology
-
The Natural Course of Adult-Onset Food Protein-Induced Enterocolitis Syndrome
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 11, pp. 2986-2992
2021
-
El libro de las enfermedades alérgicas
ed. lit.
Fundación BBVA
-
IGF-1 Haploinsufficiency Causes Age-Related Chronic Cochlear Inflammation and Increases Noise-Induced Hearing Loss
Cells, Vol. 10, Núm. 7
-
Mecanismos de las reacciones alérgicas
El libro de las enfermedades alérgicas (Fundación BBVA), pp. 49-60
-
Non-ige-mediated gastrointestinal food protein-induced allergic disorders. Clinical perspectives and analytical approaches
Foods, Vol. 10, Núm. 11
-
Poor prognosis of food protein–induced enterocolitis syndrome to fish
Pediatric Allergy and Immunology, Vol. 32, Núm. 3, pp. 560-565
-
Relevant features of adult-onset food protein–induced enterocolitis syndrome
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 4, pp. 1759-1760.e1
-
Safety of new mrna vaccines against covid-19 in severely allergic patients
Journal of Investigational Allergology and Clinical Immunology
-
The applications of eHealth technologies in the management of asthma and allergic diseases
Clinical and Translational Allergy, Vol. 11, Núm. 7
2020
-
Drug challenge tests with general anesthetics: Predictive value of skin tests
Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 2, pp. 101-107
-
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
The Lancet Child and Adolescent Health, Vol. 4, Núm. 10, pp. 728-739
2019
-
Adjuvants in allergen-specific immunotherapy: Modulating and enhancing the immune response
Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 2, pp. 103-111
-
Delayed hypersensitivity reaction to lenalidomide: 2 different clinical patterns in the same patient
Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 4, pp. 309-311
-
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1599-1609.e1
-
Is self-injectable epinephrine being used by children with food allergy?
Journal of Investigational Allergology and Clinical Immunology
-
Oral food challenge in food protein-induced enterocolitis syndrome by fish: Is there any room for improvement?
International Archives of Allergy and Immunology, Vol. 179, Núm. 3, pp. 215-220
-
Survey of opinion of Spanish physicians on the role of eosinophils in asthma and other diseases
Journal of Investigational Allergology and Clinical Immunology